Argentinian gastroenterologist groups issued position statement on biosimilars use

Biosimilars/General | Posted 22/10/2021 comments 0
IBD 3

Experts from the steering committees of the Argentinian Society of Gastroenterology (SAGE), the Argentinian Federation of Gastroenterology (FAGE) and the Argentinian Group of Crohn's Disease and Ul...

More >
LATIN AMERICAN FORUM MOST READ
79 MD002389
Competition from biosimilars drives price reductions for biologicals in France
Posted 15/10/2021

The US has experienced a policy debate as to whether competition from biosimilars is th...

07 AA011110
GMP certification requirements in Chile, Cuba and Venezuela
Posted 08/10/2021

The increasingly globalized nature of commerce allows manufacturers to outsource activi...

DINAVISA V21J15LT
Biosimilars approved in Paraguay
Posted 15/10/2021

In Paraguay, the regulatory body responsible for the approval of biological drugs is th...

Home/Non‐Biological Complex Drugs
Liposome V15L11

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft guidance...

More >